Psychological distress in women at increased risk for breast cancer: the role of risk perception
Introduction
One in every ten women in Western industrialised countries will develop breast cancer during her life-time. A genetic predisposition is suspected in approximately 5–10% of all breast cancer cases. In the mid-1990s, the BRCA1 and BRCA2 genes were identified [1], [2]. Carriers of a mutation in one of these genes have a significantly increased cumulative lifetime risk (CLTR) of developing breast cancer that has been reported to be between 60% and 85% [3], [4], [5], while Antoniou and colleagues [6] recently provided evidence for lower risk percentages in breast cancer patients unselected for family history. Other breast cancer susceptibility genes may also play a role, such as CHEK2 [7], but either their role still has to be elucidated or such genes are not yet identified. Women from families with a clear family history of breast cancer where a mutation has not (yet) been found are also at increased risk, which has mainly been estimated using the risk tables developed by Claus and colleagues [8]. Since the Claus model does not account for bilateral breast cancer, the occurrence of breast cancer in multiple family members as well as the occurrence of ovarian cancer, other models are also being developed, and may eventually provide more accurate risk estimations [9]. One of the management options for women at increased risk is regular surveillance mostly by use of an annual mammography and biannual clinical breast examination. A monthly breast self-examination is recommended.
Perceptions of the risk of developing breast cancer in `high-risk' women are frequently found to be inaccurate, but also show a wide variability. In the literature, between 9% and 57% of `high-risk' women are reported to have accurate risk perceptions [10], [11], [12], [13], [14], [15], [16]. This variability can partly be explained by which the risk perception is measured, either before or after counselling. Meiser and colleagues conducted a meta-analytical review in order to obtain an effect size of the impact of genetic counselling on the accuracy of risk perception. They found a significant medium effect size (r=0.56;P<0.01) which demonstrates the efficacy of genetic counselling in improving risk perception [17]. Despite improvements in accurate risk perception after genetic counselling, there are still women who continue to overestimate or underestimate their breast cancer risk [10], [12], [14], [18], [19], [20], [21]. Several reasons for sustained inaccurate risk perceptions can be given. Lacking sufficient numerical skills or overall education levels can cause inaccurate risk perceptions [22]. Processing information about heredity can lead to wrong assumptions about one's risk of developing the disease, for instance on the basis of physical or psychological identification with an affected relative [23]. Personal experience with breast cancer in the family may obstruct the adoption of realistic risk perceptions [24]. The format in which the risk information is given may also influence the accuracy of recall of the risk estimation. Watson and colleagues found that recall of risk is more accurate when risk information is given in Odds Ratios than in other formats [12].
Women with higher risk perceptions often display more psychological distress, both breast cancer-specific and general [11], [12], [15], [16], [20], [25]. Hopwood and colleagues [16] found more cancer worries in overestimators than in women who underestimated or who estimated their risk accurately. Meiser and colleagues [15] found that overestimators had both higher state anxiety, as well as breast cancer anxiety. These data result from studies that addressed the level of knowledge of risk, i.e., the cognitive dimension. Women had to indicate how they think about their own risk by ticking a number. Hopwood suggested that not only the objective risk information may be of importance, but also the way this information is processed by the individual [13]. This led us to hypothesise that, women may give an accurate or inaccurate estimation of their breast cancer risk, the way they feel about this risk may be very much lower or higher. Further, this felt or affective risk perception may have a more powerful association with psychological distress than cognitive risk perception.
In November 1999, the observational magnetic resonance imaging screening (MRISC) study started in the Netherlands evaluating a surveillance program for women at increased risk of breast cancer due to a genetic or familial predisposition (MRISC-part A). The programme consisted of an annual magnetic resonance imaging (MRI) scan and mammography, biannual physical examination and monthly breast self-examination. The participants were classified into one of three risk categories, corresponding to a CLTR of either more than 60%, a CLTR of 30–50%, and a CLTR of 15–30% [26]. A psychological follow-up study started in September 2000 (MRISC-part B). Herein, we describe the association between psychological distress and risk perception in women participating in the MRISC-part B. First, we differentiated between a cognitive and an affective component of risk perception in the three different levels of objective risk status. Next, we determined the association between general and breast cancer-specific distress, and cognitive and affective risk perception. We hypothesised that the women in the different risk categories differed in the perception of their risk; in a way that higher risk perceptions were associated with elevated levels of both types of psychological distress; and that affective risk perception was more prominently associated with psychological distress than cognitive risk perception.
Section snippets
Participants
A total of 351 women were included in this study; 322 women participated in the MRISC-A study and 29 women adhered to surveillance, but were not enrolled in MRISC-A. One hundred and eight women from MRISC-A did not participate in the psychological follow-up study. At entry, participants did not have a history of breast cancer, and had a cumulative lifetime risk of developing breast cancer of at least 15%, based on risk tables by Claus and colleagues [8]. For this study, participants were
Sample characteristics
The characteristics of 351 participants are shown in Table 1. The women who did not want to participate in the psychological follow-up study did not differ significantly from the women who did participate, with respect to age and risk status. The three objective risk categories were not equally represented; 11.4% (n=40) of the sample was BRCA1 or BRCA2 mutation carriers, 56.7% (n=199) of the women belonged to category 2, and 31.9% (n=112) belonged to risk category 3. The mean age of the total
Discussion
Our findings underscore Hopwood's notion that the affective risk perception is important [13] and is profoundly associated with psychological distress. Moreover, this association remains irrespective of the accuracy of risk perception.
Less than half of the women in our sample accurately estimated their personal risk of developing breast cancer. Underestimation of risk was most prominent in risk category 2, whereas overestimation was most prominent in risk category 3. Several factors can explain
Acknowledgements
This study was supported by the Dutch Health Insurance Council. We would like to thank all the women who participated in this study.
References (35)
- et al.
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: the breast cancer linkage consortium
Am. J. Hum. Genet.
(1998) - et al.
Population-based study of risk of breast cancer in carriers of BRCA2 mutation
Lancet
(1998) - et al.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
Am. J. Hum. Genet.
(2003) - et al.
What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review
Soc. Sci. Med.
(2002) - et al.
A family history of breast cancer: women's experiences from a theoretical perspective
Soc. Sci. Med.
(2001) - et al.
Family history of breast cancer and local recurrence after breast – conserving therapy. The Dutch study group on local recurrence after breast conservation (BORST)
Eur. J. Cancer
(1999) - et al.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Science
(1994) - et al.
Identification of the breast cancer susceptibility gene BRCA2
Nature
(1995) - et al.
BRCA1 and BRCA2: from molecular genetics to clinical medicine
J. Clin. Oncol.
(1998) - et al.
Low-penetrance susceptibility to breast cancer due to CHEK2 (*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
Nat. Genet.
(2002)
Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction
Cancer
Risk estimation for healthy women from breast cancer families: new insights and new strategies
Cancer Epidemiol. Biomarkers Prev.
The impact of genetic counselling on risk perception in women with a family history of breast cancer
Br. J. Cancer
Psychological counseling strategies for women at risk of breast cancer
J. Natl. Cancer Inst. Monogr.
Family history of breast cancer: what do women understand and recall about their genetic risk?
J. Med. Genet.
Genetic risk counselling for breast cancer families
Eur. J. Cancer
The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer
Br. J. Cancer
Cited by (54)
Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: A systematic review and meta-analysis
2020, Patient Education and CounselingCitation Excerpt :These discrepancies are potentially consequential. Risk perception, particularly when assessed using high quality measures, has been shown to predict behaviour [8], and cancer risk perception specifically is associated with health-related quality of life, depression, anxiety and cancer worry [9–11]. Understanding the impact of providing personalised cancer risk information on perceptions of risk and psychological responses is, therefore, important.
Genetic testing expanded
2019, Clinical Genome Sequencing: Psychological ConsiderationsSummary of key areas for research
2019, Clinical Genome Sequencing: Psychological ConsiderationsPsychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
2012, Gynecologic OncologySurveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review
2012, Critical Reviews in Oncology/Hematology